Literature DB >> 11799442

International response to the HIV/AIDS epidemic: planning for success.

P Piot1, A M Coll Seck.   

Abstract

More assertive political leadership in the global response to AIDS in both poor and rich countries culminated in June 2001 at the UN General Assembly Special Session on AIDS. Delegates made important commitments there, and endorsed a global strategy framework for shifting the dynamics of the epidemic by simultaneously reducing risk, vulnerability and impact. This points the way to achievable progress in the fight against HIV/AIDS. Evidence of success in tackling the spread of AIDS comes from diverse programme areas, including work with sex workers and clients, injecting drug users, and young people. It also comes from diverse countries, including India, the Russian Federation, Senegal, Thailand, the United Republic of Tanzania, and Zambia. Their common feature is the combination of focused approaches with attention to the societywide context within which risk occurs. Similarly, building synergies between prevention and care has underpinned success in Brazil and holds great potential for sub-Saharan Africa, where 90% reductions have been achieved in the prices at which antiretroviral drugs are available. Success also involves overcoming stigma, which undermines community action and blocks access to services. Work against stigma and discrimination has been effectively carried out in both health sector and occupational settings. Accompanying attention to the conditions for success against HIV/AIDS is global consensus on the need for additional resources. The detailed estimate of required AIDS spending in low- and middle-income countries is US$ 9.2 billion annually, compared to the $ 2 billion currently spent. Additional spending should be mobilized by the new global fund to fight AIDS, tuberculosis and malaria, but needs to be joined by additional government and private efforts within countries, including from debt relief. Commitment and capacity to scale up HIV prevention and care have never been stronger. The moment must be seized to prevent a global catastrophe.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11799442      PMCID: PMC2566707     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  18 in total

Review 1.  Tackling HIV in resource poor countries.

Authors:  J S Mukherjee; P E Farmer; D Niyizonkiza; L McCorkle; C Vanderwarker; P Teixeira; J Y Kim
Journal:  BMJ       Date:  2003-11-08

Review 2.  Priorities for antiretroviral therapy research in sub-Saharan Africa: a 2002 consensus conference in Zambia.

Authors:  Isaac Zulu; Paula Schuman; Rosemary Musonda; Elwyn Chomba; Kasonde Mwinga; Moses Sinkala; Maureen Chisembele; Peter Mwaba; Dorothy Kasonde; Sten H Vermund
Journal:  J Acquir Immune Defic Syndr       Date:  2004-07-01       Impact factor: 3.731

3.  Will Africa achieve the Millennium Development Goals?

Authors:  Adamson S Muula
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

4.  Using a clinic based creativity initiative to reduce HIV related stigma at the Infectious Diseases Institute, Mulago National Referral Hospital, Uganda.

Authors:  S Neema; L M Atuyambe; E Otolok-Tanga; C Twijukye; A Kambugu; L Thayer; K McAdam
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

5.  The 30-year war on AIDS: have we reached the tipping point?

Authors:  Thomas C Quinn
Journal:  Sex Transm Dis       Date:  2011-12       Impact factor: 2.830

6.  Adherence to anti retroviral therapy (ART) during Muslim Ramadan fasting.

Authors:  A G Habib; J C Shepherd; M K L Eng; M Babashani; J Jumare; U Yakubu; U I Gebi; M Saad; H Ibrahim; W A Blattner
Journal:  AIDS Behav       Date:  2008-06-03

7.  Global Health Governance at a Crossroads.

Authors:  Nora Y Ng; Jennifer Prah Ruger
Journal:  Glob Health Gov       Date:  2011-06-21

8.  Corruption and oil exploration: expert agreement about the prevention of HIV/AIDS in the Niger Delta of Nigeria.

Authors:  Isidore A Udoh; Ronald M Stammen; Joanne E Mantell
Journal:  Health Educ Res       Date:  2007-09-28

9.  Cost-effectiveness of models for prevention of vertical HIV transmission - voluntary counseling and testing and choices of drug regimen.

Authors:  Yot Teerawattananon; Theo Vos; Viroj Tangcharoensathien; Miranda Mugford
Journal:  Cost Eff Resour Alloc       Date:  2005-07-18

10.  Treatment outcomes in palliative care: the TOPCare study. A mixed methods phase III randomised controlled trial to assess the effectiveness of a nurse-led palliative care intervention for HIV positive patients on antiretroviral therapy.

Authors:  Keira Lowther; Victoria Simms; Lucy Selman; Lorraine Sherr; Liz Gwyther; Hellen Kariuki; Aabid Ahmed; Zipporah Ali; Rachel Jenkins; Irene J Higginson; Richard Harding
Journal:  BMC Infect Dis       Date:  2012-11-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.